Information  X 
Enter a valid email address

Assura plc (AGR)

  Print   

Thursday 21 April, 2022

Assura plc

Notice of Results & Investor Presentations

RNS Number : 8205I
Assura PLC
21 April 2022
 

21 April 2022

Assura plc

Notice of Year End Results & Investor Presentations

Assura plc ("the Company"), the UK's leading primary care property investor and developer will announce Annual Results for the year ended 31 March 2022 on Wednesday 18 May 2022.

A presentation for analysts and investors will be released at 7.00 am BST which can be viewed at the following link:

https://webcasting.brrmedia.co.uk/broadcast/625e82ca841dd838fd0be3a3  

A live Q&A session with members of the senior management team will be held at 11.30 am BST. The Q&A session can be accessed either via the webcast link or conference call details below.

Q&A option: webcast (audio):  https://webcasting.brrmedia.co.uk/broadcast/625e853d841dd838fd0be4c8  

Q&A option: conference call:  0800 279 6877 or +44 (0)330 165 4012 (state "Assura Results Q&A" or code "1305353")

Investor Meet Company presentation

Separately, Jonathan Murphy (CEO) and Jayne Cottam (CFO) will host a live presentation relating to the Annual Results for the year ended 31 March 2022 via the Investor Meet Company platform on Thursday 9 June 2022 at 11.30 am BST.

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via the Investor Meet Company dashboard until 9.00 am the day before the meeting or at any time during the live presentation. 

Investors can sign up to Investor Meet Company for free and register to follow Assura plc via this link: https://www.investormeetcompany.com/assura-plc/register-investor

Investors who already follow Assura plc on the Investor Meet Company platform will automatically be invited to the event.

- Ends -

 

For more information, please contact:

Assura plc
David Purcell, Investor Relations Director

Tel: 01925 945354
E mail: [email protected]

Finsbury Glover Hering

Gordon Simpson
James Thompson

Tel: 0207 251 3801
Email: [email protected]

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at £2,595 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

Assura plc LEI code: 21380026T19N2Y52XF72

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORBKKBQCBKDKQB

a d v e r t i s e m e n t